ConductScience.org, home

Paper40717023

Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting.

Hussain M and 2 others. FEBS J, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting. Papers, record 40717023. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40717023

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting.
PubMed
Journal
FEBS J
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hussain MMadihah
2Tejeda GSGonzalo S
3Baillie GSGeorge Shttps://orcid.org/0000-0003-2469-6316

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclic Nucleotide Phosphodiesterases, Type 4Major topic
Protein Processing, Post-TranslationalMajor topic
Phosphodiesterase 4 InhibitorsMajor topic
Humans
Cyclic AMP
Animals
Signal Transduction
Molecular Targeted Therapy

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/y00364/1Medical Research CouncilUnited KingdomPubMed
SP/16/3/32317British Heart FoundationUnited KingdomPubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131388135Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.Nat Rev Drug Discov2019https://conductscience.org/library/papers/31388135PubMed
215066910Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.Br J Pharmacol2004https://conductscience.org/library/papers/15066910PubMed
310022832The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.EMBO J1999https://conductscience.org/library/papers/10022832PubMed
415182229PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.Biochem J2004https://conductscience.org/library/papers/15182229PubMed
525680530The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus.FEBS Lett2015https://conductscience.org/library/papers/25680530PubMed
620196770Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.Biochem J2010https://conductscience.org/library/papers/20196770PubMed
735091346A chemical method for genome- and proteome-wide enrichment and O-GlcNAcylation profiling of chromatin-associated proteins.Talanta2022https://conductscience.org/library/papers/35091346PubMed
822975349Prolyl hydroxylase domain protein 2 regulates the intracellular cyclic AMP level in cardiomyocytes through its interaction with phosphodiesterase 4D.Biochem Biophys Res Commun2012https://conductscience.org/library/papers/22975349PubMed
924815749Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.Cell Signal2014https://conductscience.org/library/papers/24815749PubMed
1038797258Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.Exp Cell Res2024https://conductscience.org/library/papers/38797258PubMed
1123514139Decoding the SUMO signal.Biochem Soc Trans2013https://conductscience.org/library/papers/23514139PubMed
1226192746The role of ventral striatal cAMP signaling in stress-induced behaviors.Nat Neurosci2015https://conductscience.org/library/papers/26192746PubMed
1335042991PROTAC targeted protein degraders: the past is prologue.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35042991PubMed
1410829034The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution.J Biol Chem2000https://conductscience.org/library/papers/10829034PubMed
1539673076Targeted protein degradation of PDE4 shortforms by a novel proteolysis targeting chimera.FEBS J2025https://conductscience.org/library/papers/39673076PubMed
1624555506The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).Biochem J2014https://conductscience.org/library/papers/24555506PubMed
1739851300Artificial Intelligence Transforming Post-Translational Modification Research.Bioengineering (Basel)2024https://conductscience.org/library/papers/39851300PubMed
1835695071A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation.EMBO Rep2022https://conductscience.org/library/papers/35695071PubMed
1927908835Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance.Mol Cell Endocrinol2017https://conductscience.org/library/papers/27908835PubMed
2025831493Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25831493PubMed

See all 64 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41157273PDE4-Selective Inhibition in Chronic Obstructive Pulmonary Disease and Pulmonary Fibrosis: Different Agents or Different Targets?Life (Basel)2025https://conductscience.org/library/papers/41157273

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDE4A5141PubTator's text mininghttps://conductscience.org/library/genes/5141

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40717023

GET https://conductscience.org/api/papers/v1/40717023/references?page=2